PITTSBURGH, Nov. 27 /Xinhua-PRNewswire/ -- Mylan Inc. (NYSE: MYL) today announced the appointment of Steven G. Zylstra as Vice President, Global Corporate Communication and Public Relations. Mr. Zylstra will manage and oversee all internal and external communications and provide communications and public relations counsel to members of Mylan's global senior management team in their various roles across the Company.
Mr. Zylstra joins Mylan from the Pittsburgh Technology Council and the Pittsburgh Biomedical Development Corporation where he served as President and CEO. He joined the Pittsburgh Technology Council et al after serving as Director, Business Development, for Simula Technologies Inc. Prior to joining Simula, Mr. Zylstra served as General Manager, General Pneumatics Corporation's Western Research Center, and, prior to that, he served as Technical Manager for Bendix Guidance Systems Division. Mr. Zylstra joins Mylan with nearly 30 years of public relations, senior management, business development, marketing, government relations and engineering experience, including the past seven years as a chief spokesman for the technology and manufacturing industries in southwestern Pennsylvania.
Mylan Vice Chairman and CEO Robert J. Coury said: "In Steve, Mylan is adding yet another highly-seasoned, top-notch leader to further strengthen our senior management team. His rich and diverse background steeped in technology and manufacturing, makes him especially well suited to articulate the dynamic future and intrinsic complexities of both Mylan and of the generic and specialty pharmaceuticals industries."
Mr. Zylstra said: "I am elated to be joining Mylan at this transformational period in the Company's already prosperous history. I look forward to working with the members of an extraordinary global management team and supporting them and their operations with a world-class communications program as Mylan becomes the leading quality generic and specialty pharmaceutical company in the worlAAAAAAAAA> Mr. Zylstra earned a bachelor's of science degree from Western Michigan University.
Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The Company offers one of the industry's broadest and highest quality product portfolios, a robust product pipeline and a global commercial footprint through operations in more than 90 countries. Through its controlling interest in Matrix Laboratories Limited, Mylan has direct access to one of the largest active pharmaceutical ingredient (API) manufacturers in the world. Dey L.P., Mylan's fully integrated specialty business, provides the Company with innovative and diversified opportunities in the respiratory and allergy therapeutic areas. For more information about Mylan, please visit http://www.mylan.com .